SK282060B6 - Kombinácia inhibítora spätnej absorpcie 5-ht so selektívnou protilátkou 5-ht1a, spôsob jej prípravy, farmaceutická formulácia s jej obsahom, jej použitie a kit s jej obsahom - Google Patents

Kombinácia inhibítora spätnej absorpcie 5-ht so selektívnou protilátkou 5-ht1a, spôsob jej prípravy, farmaceutická formulácia s jej obsahom, jej použitie a kit s jej obsahom Download PDF

Info

Publication number: SK282060B6
Authority: SK; Slovakia
Prior art keywords: dihydro; benzopyran; fluoro; combination; selective
Prior art date: 1995-04-27

Application number

SK1429-97A

Other languages

English (en)

Slovak (sk)

Other versions

SK142997A3 (en

Inventor

John Evenden

Seth-Olov Thorberg

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-27

Filing date

1996-04-23

Publication date

2001-10-08

1996-04-23 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1998-12-02 Publication of SK142997A3 publication Critical patent/SK142997A3/sk

2001-10-08 Publication of SK282060B6 publication Critical patent/SK282060B6/sk

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SK1429-97A 1995-04-27 1996-04-23 Kombinácia inhibítora spätnej absorpcie 5-ht so selektívnou protilátkou 5-ht1a, spôsob jej prípravy, farmaceutická formulácia s jej obsahom, jej použitie a kit s jej obsahom SK282060B6 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9501567A SE9501567D0 (sv)	1995-04-27	1995-04-27	A new combination
PCT/SE1996/000526 WO1996033710A1 (en)	1995-04-27	1996-04-23	A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist

Publications (2)

Publication Number	Publication Date
SK142997A3 SK142997A3 (en)	1998-12-02
SK282060B6 true SK282060B6 (sk)	2001-10-08

Family

ID=20398119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1429-97A SK282060B6 (sk)	1995-04-27	1996-04-23	Kombinácia inhibítora spätnej absorpcie 5-ht so selektívnou protilátkou 5-ht1a, spôsob jej prípravy, farmaceutická formulácia s jej obsahom, jej použitie a kit s jej obsahom

Country Status (30)

Country	Link
US (5)	US5962514A (is)
EP (1)	EP0822813B1 (is)
JP (1)	JPH11504037A (is)
KR (1)	KR100419810B1 (is)
CN (1)	CN1102386C (is)
AR (1)	AR002990A1 (is)
AT (1)	ATE216579T1 (is)
BR (1)	BR9608252A (is)
CA (1)	CA2218181A1 (is)
CZ (1)	CZ335697A3 (is)
DE (1)	DE69620878T2 (is)
DK (1)	DK0822813T3 (is)
EE (1)	EE03553B1 (is)
ES (1)	ES2175089T3 (is)
HK (1)	HK1002853A1 (is)
HU (1)	HUP9801946A3 (is)
IL (1)	IL117988A0 (is)
IS (1)	IS1821B (is)
NO (1)	NO317057B1 (is)
NZ (1)	NZ306602A (is)
PL (1)	PL183997B1 (is)
PT (1)	PT822813E (is)
RU (1)	RU2183955C2 (is)
SE (1)	SE9501567D0 (is)
SK (1)	SK282060B6 (is)
TR (1)	TR199701254T1 (is)
TW (1)	TW458777B (is)
WO (1)	WO1996033710A1 (is)
YU (1)	YU25696A (is)
ZA (1)	ZA962982B (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination
SE9703374D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	A new combination
AU4100699A (en) *	1998-05-28	1999-12-13	Sepracor, Inc.	Compositions and methods employing r(-) fluoxetine and other active ingredients
SE9803158D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
SE9803157D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
SE9803155D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
SE9803156D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
UA77650C2 (en) *	1999-12-06	2007-01-15	Lundbeck & Co As H	Use of serotonin reuptake inhibitor in combination with deramcyclane
US6331233B1 (en)	2000-02-02	2001-12-18	Honeywell International Inc.	Tantalum sputtering target with fine grains and uniform texture and method of manufacture
EP1757600A2 (en)	2000-10-13	2007-02-28	NeuroSearch A/S	Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
US20030166554A1 (en) *	2001-01-16	2003-09-04	Genset, S.A.	Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) *	2001-01-16	2003-10-02	Genset, S.A.	Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
MXPA03008777A (es) *	2001-05-01	2004-02-12	Lundbeck & Co As H	El uso de escitalopram enantiomericamente puro.
US7034059B2 (en)	2001-07-02	2006-04-25	Sepracor Inc.	Methods of using norfluoxetine
US6855735B2 (en)	2002-03-20	2005-02-15	Temple University Of The Commonwealth System Of Higher Education	Ketamine treatment of restless legs syndrome
AU2003256430A1 (en) *	2002-08-15	2004-03-03	Wyeth	AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
US20050032873A1 (en) *	2003-07-30	2005-02-10	Wyeth	3-Amino chroman and 2-amino tetralin derivatives
US7695601B2 (en) *	2006-05-09	2010-04-13	The United States Of America As Represented By The Secretary Of The Army	Electrochemical test apparatus and method for its use
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine
US20160154928A1 (en) *	2013-07-12	2016-06-02	Immuneering Corporation	Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
CA3049464A1 (en)	2017-02-14	2018-08-23	Research Triangle Institute	Proline-based neuropeptide ff receptor modulators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4698342A (en) *	1985-07-16	1987-10-06	Serotonin Industries Of Charleston	Method and compositions for controlling pain, depression and sedation
US5420151A (en) *	1989-12-22	1995-05-30	Aktiebolaget Astra	Chroman derivatives
US5616610A (en) *	1989-12-22	1997-04-01	Astra Aktiebolag	(R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination

1995
- 1995-04-27 SE SE9501567A patent/SE9501567D0/xx unknown
1996
- 1996-04-15 TW TW085104481A patent/TW458777B/zh not_active IP Right Cessation
- 1996-04-15 ZA ZA962982A patent/ZA962982B/xx unknown
- 1996-04-21 IL IL11798896A patent/IL117988A0/xx not_active IP Right Cessation
- 1996-04-23 PL PL96323083A patent/PL183997B1/pl unknown
- 1996-04-23 CA CA002218181A patent/CA2218181A1/en not_active Abandoned
- 1996-04-23 EE EE9700245A patent/EE03553B1/xx not_active IP Right Cessation
- 1996-04-23 DE DE69620878T patent/DE69620878T2/de not_active Expired - Fee Related
- 1996-04-23 US US08/640,896 patent/US5962514A/en not_active Expired - Fee Related
- 1996-04-23 JP JP8532425A patent/JPH11504037A/ja not_active Ceased
- 1996-04-23 NZ NZ306602A patent/NZ306602A/en unknown
- 1996-04-23 BR BR9608252A patent/BR9608252A/pt not_active Application Discontinuation
- 1996-04-23 CN CN96194810A patent/CN1102386C/zh not_active Expired - Fee Related
- 1996-04-23 KR KR1019970707592A patent/KR100419810B1/ko not_active IP Right Cessation
- 1996-04-23 CZ CZ973356A patent/CZ335697A3/cs unknown
- 1996-04-23 DK DK96912370T patent/DK0822813T3/da active
- 1996-04-23 HU HU9801946A patent/HUP9801946A3/hu unknown
- 1996-04-23 EP EP96912370A patent/EP0822813B1/en not_active Expired - Lifetime
- 1996-04-23 AT AT96912370T patent/ATE216579T1/de not_active IP Right Cessation
- 1996-04-23 WO PCT/SE1996/000526 patent/WO1996033710A1/en active IP Right Grant
- 1996-04-23 TR TR97/01254T patent/TR199701254T1/xx unknown
- 1996-04-23 SK SK1429-97A patent/SK282060B6/sk unknown
- 1996-04-23 ES ES96912370T patent/ES2175089T3/es not_active Expired - Lifetime
- 1996-04-23 RU RU97119427/14A patent/RU2183955C2/ru active
- 1996-04-23 PT PT96912370T patent/PT822813E/pt unknown
- 1996-04-25 AR ARP960102323A patent/AR002990A1/es not_active Application Discontinuation
- 1996-04-26 YU YU25696A patent/YU25696A/sh unknown
1997
- 1997-10-09 IS IS4585A patent/IS1821B/is unknown
- 1997-10-24 NO NO19974921A patent/NO317057B1/no unknown
1998
- 1998-03-10 HK HK98101990A patent/HK1002853A1/xx not_active IP Right Cessation
1999
- 1999-07-09 US US09/349,590 patent/US6184218B1/en not_active Expired - Fee Related
- 1999-07-09 US US09/351,069 patent/US6169098B1/en not_active Expired - Fee Related
- 1999-07-09 US US09/351,070 patent/US6172105B1/en not_active Expired - Fee Related
- 1999-07-09 US US09/351,071 patent/US6184219B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR9608252A (pt)	1999-05-04
EP0822813A1 (en)	1998-02-11
ATE216579T1 (de)	2002-05-15
TW458777B (en)	2001-10-11
KR100419810B1 (ko)	2004-04-21
NO974921L (no)	1997-12-18
US6172105B1 (en)	2001-01-09
RU2183955C2 (ru)	2002-06-27
US5962514A (en)	1999-10-05
TR199701254T1 (xx)	1998-02-21
ZA962982B (en)	1996-10-28
PL183997B1 (pl)	2002-08-30
IS4585A (is)	1997-10-09
SK142997A3 (en)	1998-12-02
SE9501567D0 (sv)	1995-04-27
US6184219B1 (en)	2001-02-06
HUP9801946A2 (hu)	2000-05-28
DK0822813T3 (da)	2002-07-29
AU5520296A (en)	1996-11-18
PT822813E (pt)	2002-10-31
EP0822813B1 (en)	2002-04-24
DE69620878D1 (de)	2002-05-29
EE9700245A (et)	1998-04-15
AU696356B2 (en)	1998-09-10
PL323083A1 (en)	1998-03-02
CZ335697A3 (cs)	1998-06-17
US6169098B1 (en)	2001-01-02
NO974921D0 (no)	1997-10-24
YU25696A (sh)	1999-06-15
ES2175089T3 (es)	2002-11-16
CA2218181A1 (en)	1996-10-31
EE03553B1 (et)	2001-12-17
CN1187768A (zh)	1998-07-15
NZ306602A (en)	1999-04-29
NO317057B1 (no)	2004-08-02
AR002990A1 (es)	1998-05-27
HK1002853A1 (en)	1998-09-25
HUP9801946A3 (en)	2000-12-28
JPH11504037A (ja)	1999-04-06
DE69620878T2 (de)	2002-11-14
WO1996033710A1 (en)	1996-10-31
IS1821B (is)	2002-08-27
KR19990008068A (ko)	1999-01-25
US6184218B1 (en)	2001-02-06
IL117988A0 (en)	1996-08-04
CN1102386C (zh)	2003-03-05

Publication	Publication Date	Title
SK282060B6 (sk)	2001-10-08	Kombinácia inhibítora spätnej absorpcie 5-ht so selektívnou protilátkou 5-ht1a, spôsob jej prípravy, farmaceutická formulácia s jej obsahom, jej použitie a kit s jej obsahom
RU2142951C1 (ru)	1999-12-20	Соединения (r)-5-карбамоил-8-фтор-3-n,n-дизамещенные-амино-3,4-дигидро-2h-1-бензопираны, фармацевтическая композиция, способ лечения и способы получения соединений
US6699877B2 (en)	2004-03-02	Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
US5616610A (en)	1997-04-01	(R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
EP0538222A1 (en)	1993-04-21	3-(N-Isopropyl-N-n-propylamino)-5-(N-isopropyl)carbamoylchroman as a selective 5-hydroxytryptamine receptor stimulant
AU696356C (en)	1999-06-03	A combination of a 5-HT uptake inhibitor with a selective 5-HT1A antagonist
KR100393505B1 (ko)	2005-09-30	신규(r)-5-카르바모일-8-플루오로-3-n,n-이치환-아미노-3,4-디히드로-2h-1-벤조피란